<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Al-Shahi Salman, Rustam</style></author><author><style face="normal" font="default" size="100%">Brock, Timothy M</style></author><author><style face="normal" font="default" size="100%">Dennis, Martin S</style></author><author><style face="normal" font="default" size="100%">Sandercock, Peter A G</style></author><author><style face="normal" font="default" size="100%">White, Philip M</style></author><author><style face="normal" font="default" size="100%">Warlow, Charles</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Research governance impediments to clinical trials: a retrospective survey.</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of the Royal Society of Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J R Soc Med</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Biomedical Research</style></keyword><keyword><style  face="normal" font="default" size="100%">Costs and Cost Analysis</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Multicenter Studies as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Organizational Policy</style></keyword><keyword><style  face="normal" font="default" size="100%">Randomized Controlled Trials as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Retrospective Studies</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007 Feb</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">100</style></volume><pages><style face="normal" font="default" size="100%">101-4</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">We sought to evaluate the delays, between-centre variations in practice, and opportunity costs attributable to delays in research governance approval of clinical trials in the United Kingdom.</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/17277284?dopt=Abstract</style></custom1></record></records></xml>